Skip to content
  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
Daily News India

Daily News India

Just another WordPress site

  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
  • Toggle search form
  • Trailblazer in the Making: The Remarkable Journey of Mohit Balchandani, Director of Bling Ping Business
  • India’s first batch of deaf football coaches receive ‘E’ License Business
  • Dev IT Reports Strong FY26 with Enhanced Digital Capabilities, Strategic Partnerships, and Expanding Growth Pipeline Business
  • Speed Presents Vroom Drag Meet 9th Edition, Powered by Hero MotoCorp and Electric Performance Partner Ultraviolette Business
  • Veganuary 2024 campaign – driving global change with a plant-based challenge Lifestyle
  • Dr. Shivanand Hulyalkar: A Visionary Leader Transforming Maharashtra National
  • Arista Vault Strikes Shark Tank Deal with Smart Travel Solutions Business
  • HelpOverseas – the most reliable Immigration Consultancy in India! Business

Akums Drugs receives EU GMP approval for two Haridwar-based manufacturing plants

Posted on July 11, 2022 By

Akums Drugs & Pharmaceuticals Ltd. has recently received European Union GMP approval for two of their manufacturing units in Haridwar.

New Delhi (India), July 11: Akums Drugs & Pharmaceuticals Ltd., the leading contract manufacturing pharmaceutical company in India, has recently acquired the stringent European Union (EU) GMP  approval for two of their manufacturing units in Haridwar. Following this prestigious nod, the gateway for several new opportunities in the European and other stringent regulatory markets is open to Akums Drugs. This move is another assent to Akums’ “Quality First” approach to work, which has now been endorsed by the EU -GMP beside all top-notch Indian and multinational pharmaceutical companies, who are already Akums’ long-standing partners.

Akums has received EU GMP approval for its two manufacturing plants. One plant manufactures solid oral dosage forms such as tablets, hard gelatin capsules, powders in sachets, etc. belonging to the general category, and Another plant manufactures large volume parenteral and small volume parenterals lines, including vials, ampoules, eyedrops, FFS  as well as for dry powder injections in the penicillin line.

Founder, Promoter and Director, Akums Drugs & Pharmaceuticals, Shri Sandeep Jain, says, “We are happy to announce that Akums Drugs has received EU GMP approval for two of our Haridwar-based manufacturing facilities, thus paving the path for new opportunities from the entire European Union as well as many other regulatory markets. We are already the largest Indian contract manufacturing company, manufacturing > 12% of country’s domestic supply, but what makes us happiest is being recognised for our “Quality First” approach. While we have been endorsed for this quality by our partners, who are also leading Indian and multinational pharmaceutical companies, the latest one from the EU GMP is very widely recognised & accepted. Congratulations to the entire team, and I hope this is the beginning of numerous possibilities for us.”

Founder, Promoter and Director Akums Drugs & Pharmaceuticals, Shri Sanjeev Jain, says, “Akums is already exporting to over 50 countries worldwide. With the esteemed EU GMP nod, we have now gained access to the most stringent global pharmaceutical markets besides the USA. These include the entire European Union, other markets like South Africa, Canada, Malaysia, Indonesia, Thailand, Australia/New Zealand and most middle-eastern countries. Since the EU GMP is their gold standard, we are welcome to cater to the pharmaceutical demands of all these geographies. With a large R&D infrastructure already in place, we are well equipped with a good basket of Products in our pipeline to expand our presence in these regulated markets. While we are extremely proud and excited to expand our presence in these markets, the Indian domestic market has always been our pride & passion and will continue to be so. The trust our partners have in us, and our Quality is paramount for us. ”

Akums Drugs & Pharmaceuticals Ltd. is India’s largest contract manufacturing pharmaceutical company, manufacturing more than 12% of India’s consumption. The organisation deals in manufacturing and exporting formulations in a broad spectrum of dosage forms & therapeutic segments. The company currently supplies to almost all Indian and multinational pharmaceutical companies across the globe and is the 67th largest employer in the country. The ten state-of-the-art facilities are dedicated to oral solid dosage forms (with separate units for beta lactum and non-beta lactum formulations), Oral liquid dosage forms, Sterile dosage forms (injectable, eye, ear & nasal), hormonal (oral and injectable), ointments & cosmetics, personal care,  Ayurvedic, food supplements & nutraceuticals and animal health care.

In a few years, the organisation has become the icon of the Indian pharmaceutical manufacturing industry and currently manufactures more than 12% of the country’s total medicinal requirements. With creme-de-la-creme of dedicated pharmaceutical personnel and standardised practices, Akums has been successful in attaining national and international accreditations and building trust-based on efficacy, safety & quality. The organisation is certified with WHO-GMP, ISO 9001:2015, ISO 14001:2015 certificates and various international accreditations, like; ANVISA, Brazil, NAFDAC, Nigeria, FDB, Ghana, PMPB, Malawi, amongst others and exports to 53 countries across the world.

If you have any objection to this press release content, kindly contact pr.error.rectification@gmail.com to notify us. We will respond and rectify the situation in the next 24 hours.

Business Tags:Business

Post navigation

Previous Post: KPar Smart Products Announces 1 year report on Smart Cities
Next Post: La Excellence announced the launch of its Batch-2 for students aspiring to enter into the Civil Services in Telangana on July 11

Related Posts

  • Bon Voyagers Makes Strong Impact on India’s Tourism Through Personalised Travel Business
  • BigBloc Construction Ltd reports Net Profit of Rs. 7.70 crore in Q3FY23, rise of 81.6% Y-o-Y Business
  • Tallyplug an easy mobile accessible Tally sport system launched by Tallyplug Technologies Business
  • A Simple Guide to Start Investing in the Indian Share Market Business
  • Prime Cable Industries Limited Reports 66 Percent Revenue Growth in FY26; Secures Largest-ever Order Business
  • Why Jaipur is the Best Destination for Management Education? Business

Recent Posts

  • From Projects To Assets: The Next Phase Of Growth
  • How Cash Ur Drive is building an advertising layer on India’s new transit infrastructure
  • Leading 5 Best Judiciary Coaching in Delhi: The Ultimate Guide to Judicial Services Preparation
  • Shiv Mandlik’s Robot Reunites India’s Broken Heritage, and Wins Bronze at WRO India
  • Eco Warrior Awards 2026: Bhupender Yadav Calls Conservation a National Responsibility, Honours India’s Environmental Champions

Recent Comments

  • Unknown on Participants Reap Rewards in Wellman’s 8-Week Digital Campaign: IPL Tickets, Autographed Virat Kohli Merchandise, and More!
  • Introducing My Food Xpert: India’s Top Rated Food Consulting Company for the Food & Nutraceutical Industry Business
  • Meyer Vitabiotics Makes History on World Osteoporosis Day, Secures Spot in Asia Book of Records Health
  • Hettich Brings Its Magical Experience to Solapur with a New Hettich Exclusive (HeX) Store Launch Business
  • Augnito Announces its AI Week of Rest: “All In” to recharge, prevent burnout Business
  • Sravani Hospitals Kukatpally Branch Successfully Inaugurated on Dussehra Business
  • ah! Ventures sets up INR 150 crores Angel Fund to back early-stage GLOCAL start-ups in India Business
  • Gen Z Valentine Economy: 1 Generation, Many Industries Winning Big Business
  • First-ever Chess for Kids book in Hindi with story-telling narrative Press Release

Copyright © 2026 Daily News India.

Powered by PressBook News WordPress theme